The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 01, 2023

Filed:

Feb. 05, 2020
Applicant:

Ammr Joint Venture, La Jolla, CA (US);

Inventors:

Regis Peytavi, Costa Mesa, CA (US);

Kiana Aran, Pasadena, CA (US);

Brett Goldsmith, San Diego, CA (US);

Alexander Kane, Santa Cruz, CA (US);

Assignee:

Cardea Bio, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/10 (2006.01); C12N 9/22 (2006.01); C12N 15/11 (2006.01); B01L 3/00 (2006.01); G16B 50/30 (2019.01);
U.S. Cl.
CPC ...
C12N 15/1013 (2013.01); B01L 3/5025 (2013.01); B01L 3/502707 (2013.01); B01L 3/502715 (2013.01); B01L 3/502761 (2013.01); C12N 9/22 (2013.01); C12N 15/102 (2013.01); C12N 15/111 (2013.01); B01L 2200/027 (2013.01); B01L 2200/0668 (2013.01); B01L 2300/022 (2013.01); B01L 2300/0636 (2013.01); C12N 2310/20 (2017.05); G16B 50/30 (2019.02);
Abstract

For enhanced selection of efficient targeted genome manipulating agents, an apparatus includes first and second chip-based biosensors having one or more sensing surfaces configured to detect biomolecular binding interactions between a nucleic acid sample and a targeted genome manipulating agent functionalized to a capture surface within a sensing range of the one or more sensing surfaces. The first chip-based biosensor uses a nucleic acid sample incubated with a blocking agent that blocks on-target binding and the second chip-based biosensor holds a nucleic acid sample that omits the blocking agent. A measurement apparatus measures first and second sets of response signals produced in response to the biomolecular binding interactions occurring between the nucleic acid sample and the targeted genome manipulating agent. An analysis module determines the genome manipulating efficiency parameters of the targeted genome manipulating agent. A system and a method perform the functions of the apparatus.


Find Patent Forward Citations

Loading…